Publication:
Synthesis and preliminary anticancer activity of new 1,4-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H-1,2,4-triazoline-5-thiones

Simple item page
dc.contributor.authorsDuran, A; Dogan, HN; Rollas, S
dc.date.accessioned2022-03-12T15:58:12Z
dc.date.accessioned2026-01-11T10:27:22Z
dc.date.available2022-03-12T15:58:12Z
dc.date.issued2002
dc.description.abstract1,4-Dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H-L2,4-triazolinc-5-thiones were synthesized. The structures of original eight compounds were confirmed by elemental analysis,H-1 NMR and mass spectral methods. One of the compounds (3a) was tested in vitro for its anticancer activity against 52 human tumor cell lines. (C) 2002 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
dc.identifier.doi10.1016/S0014-827X(02)01248-X
dc.identifier.issn0014-827X
dc.identifier.pubmed12164214
dc.identifier.urihttps://hdl.handle.net/11424/223984
dc.identifier.wosWOS:000177620000010
dc.language.isoeng
dc.publisherELSEVIER SCIENCE SA
dc.relation.ispartofFARMACO
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subject1,2,4-triazoline-5-thione derivatives
dc.subjectsynthesis
dc.subjectanticancer activity
dc.subjectSTRUCTURE ELUCIDATION
dc.titleSynthesis and preliminary anticancer activity of new 1,4-dihydro-3-(3-hydroxy-2-naphthyl)-4-substituted-5H-1,2,4-triazoline-5-thiones
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPage564
oaire.citation.issue7
oaire.citation.startPage559
oaire.citation.titleFARMACO
oaire.citation.volume57

Files

Collections

Araştırma Çıktıları